- Home
- IPWR vs SNTI Comparison
IPWR vs SNTI Comparison
Compare IPWR & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPWR
- SNTI
- Stock Information
- Founded
- IPWR 2007
- SNTI 2016
- Country
- IPWR United States
- SNTI United States
- Employees
- IPWR N/A
- SNTI N/A
- Industry
- IPWR Industrial Machinery/Components
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- IPWR Industrials
- SNTI Health Care
- Exchange
- IPWR Nasdaq
- SNTI Nasdaq
- Market Cap
- IPWR 52.8M
- SNTI 53.6M
- IPO Year
- IPWR 2013
- SNTI N/A
- Fundamental
- Price
- IPWR $4.86
- SNTI $1.81
- Analyst Decision
- IPWR Hold
- SNTI Strong Buy
- Analyst Count
- IPWR 1
- SNTI 3
- Target Price
- IPWR N/A
- SNTI $9.67
- AVG Volume (30 Days)
- IPWR 61.2K
- SNTI 285.6K
- Earning Date
- IPWR 11-13-2025
- SNTI 11-12-2025
- Dividend Yield
- IPWR N/A
- SNTI N/A
- EPS Growth
- IPWR N/A
- SNTI N/A
- EPS
- IPWR N/A
- SNTI N/A
- Revenue
- IPWR $19,240.00
- SNTI N/A
- Revenue This Year
- IPWR N/A
- SNTI N/A
- Revenue Next Year
- IPWR $9,900.00
- SNTI $150.00
- P/E Ratio
- IPWR N/A
- SNTI N/A
- Revenue Growth
- IPWR N/A
- SNTI N/A
- 52 Week Low
- IPWR $3.77
- SNTI $1.26
- 52 Week High
- IPWR $8.62
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- IPWR 39.66
- SNTI 44.73
- Support Level
- IPWR $5.25
- SNTI $1.92
- Resistance Level
- IPWR $5.77
- SNTI $2.29
- Average True Range (ATR)
- IPWR 0.39
- SNTI 0.17
- MACD
- IPWR -0.05
- SNTI -0.04
- Stochastic Oscillator
- IPWR 14.45
- SNTI 1.33
About IPWR Ideal Power Inc.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.